News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
719,196 Results
Type
Article (42784)
Company Profile (295)
Press Release (676117)
Multimedia
Podcasts (81)
Webinars (13)
Section
Business (210752)
Career Advice (2104)
Deals (36672)
Drug Delivery (108)
Drug Development (83148)
Employer Resources (175)
FDA (16600)
Job Trends (15421)
News (356555)
Policy (33970)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (5)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2609)
Accelerated approval (5)
Adcomms (21)
Allergies (87)
Alliances (51524)
ALS (92)
Alzheimer's disease (1394)
Antibody-drug conjugate (ADC) (131)
Approvals (16601)
Artificial intelligence (265)
Autoimmune disease (23)
Automation (16)
Bankruptcy (371)
Best Places to Work (11780)
BIOSECURE Act (20)
Biosimilars (111)
Biotechnology (188)
Bladder cancer (66)
Brain cancer (28)
Breast cancer (274)
Cancer (2206)
Cardiovascular disease (179)
Career advice (1763)
Career pathing (31)
CAR-T (147)
Cell therapy (414)
Cervical cancer (19)
Clinical research (67531)
Collaboration (838)
Compensation (525)
Complete response letters (25)
COVID-19 (2665)
CRISPR (43)
C-suite (239)
Cystic fibrosis (103)
Data (2110)
Decentralized trials (2)
Denatured (31)
Depression (44)
Diabetes (267)
Diagnostics (6451)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (111)
Drug shortages (28)
Duchenne muscular dystrophy (93)
Earnings (88220)
Editorial (39)
Employer branding (21)
Employer resources (149)
Events (115208)
Executive appointments (723)
FDA (17835)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (754)
Gene editing (107)
Generative AI (21)
Gene therapy (305)
GLP-1 (745)
Government (4541)
Grass and pollen (5)
Guidances (52)
Healthcare (19051)
Huntington's disease (24)
IgA nephropathy (25)
Immunology and inflammation (122)
Indications (29)
Infectious disease (2808)
Inflammatory bowel disease (138)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (94)
Interviews (326)
IPO (16803)
IRA (47)
Job creations (4061)
Job search strategy (1501)
Kidney cancer (10)
Labor market (38)
Layoffs (486)
Leadership (17)
Legal (8387)
Liver cancer (74)
Lung cancer (314)
Lymphoma (149)
Machine learning (6)
Management (59)
Manufacturing (310)
MASH (67)
Medical device (13465)
Medtech (13470)
Mergers & acquisitions (20395)
Metabolic disorders (694)
Multiple sclerosis (77)
NASH (17)
Neurodegenerative disease (90)
Neuropsychiatric disorders (29)
Neuroscience (1933)
NextGen: Class of 2025 (6656)
Non-profit (4533)
Northern California (2611)
Now hiring (39)
Obesity (374)
Opinion (230)
Ovarian cancer (74)
Pain (91)
Pancreatic cancer (82)
Parkinson's disease (148)
Partnered (21)
Patents (234)
Patient recruitment (106)
Peanut (49)
People (59322)
Pharmaceutical (91)
Pharmacy benefit managers (19)
Phase I (20948)
Phase II (29708)
Phase III (22266)
Pipeline (1151)
Policy (148)
Postmarket research (2656)
Preclinical (8888)
Press Release (68)
Prostate cancer (102)
Psychedelics (31)
Radiopharmaceuticals (251)
Rare diseases (391)
Real estate (6286)
Recruiting (67)
Regulatory (23139)
Reports (46)
Research institute (2379)
Resumes & cover letters (358)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (74)
Series A (131)
Series B (84)
Service/supplier (12)
Sickle cell disease (55)
Southern California (2246)
Special edition (15)
Spinal muscular atrophy (151)
Sponsored (30)
Startups (3733)
State (2)
Stomach cancer (14)
Supply chain (68)
Tariffs (36)
The Weekly (48)
United States (22715)
Vaccines (697)
Venture capitalists (41)
Weight loss (251)
Women's health (35)
Worklife (15)
Date
Today (103)
Last 7 days (656)
Last 30 days (2498)
Last 365 days (33294)
2025 (10030)
2024 (35814)
2023 (40686)
2022 (51843)
2021 (56387)
2020 (54864)
2019 (47468)
2018 (35832)
2017 (33202)
2016 (32760)
2015 (38723)
2014 (32604)
2013 (27729)
2012 (29806)
2011 (30565)
2010 (28583)
Location
Africa (785)
Alabama (52)
Alaska (7)
Arizona (237)
Arkansas (14)
Asia (40774)
Australia (6548)
California (5972)
Canada (1981)
China (518)
Colorado (263)
Connecticut (266)
Delaware (142)
Europe (87525)
Florida (882)
Georgia (202)
Idaho (57)
Illinois (533)
India (26)
Indiana (314)
Iowa (11)
Japan (161)
Kansas (103)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (880)
Massachusetts (4486)
Michigan (218)
Minnesota (386)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1696)
New Mexico (29)
New York (1699)
North Carolina (973)
North Dakota (7)
Northern California (2611)
Ohio (200)
Oklahoma (14)
Oregon (39)
Pennsylvania (1346)
Puerto Rico (11)
Rhode Island (32)
South America (1166)
South Carolina (22)
South Dakota (1)
Southern California (2246)
Tennessee (101)
Texas (890)
Utah (179)
Virginia (149)
Washington D.C. (61)
Washington State (552)
West Virginia (3)
Wisconsin (54)
719,196 Results for "king pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Turing Medical Names Transformative Med Tech Leader Kevin King as President and Chief Executive Officer
April 15, 2025
·
2 min read
Press Releases
BiaCure CEO Laura King Appointed to Tactile Medical Board of Directors
January 16, 2025
·
1 min read
Press Releases
David P. King Joins Truvian’s Advisory Board
January 13, 2025
·
2 min read
Business
TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors
TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced the appointment of Thomas B. King to its Board of Directors.
December 13, 2023
·
5 min read
Press Releases
Dianthus Therapeutics Strengthens Strategic Commercial Leadership With Appointment of John C. King as Chief Commercial Officer and Welcomes Sujay Kango, A Seasoned Commercial Leader, to Board of Directors
March 5, 2025
·
7 min read
Press Releases
Avanos Medical, Inc. to Present at the 2024 CL King Annual Best Ideas Conference
September 9, 2024
·
1 min read
Press Releases
Nika Pharmaceuticals, Inc. (NIKA) Latest Developments
April 14, 2025
·
2 min read
BioMidwest
Avanos Medical, Inc. to Present at the CL King Annual Best Ideas Conference
Avanos Medical, Inc. announced that Michael Greiner, senior vice president, chief financial officer, and chief transformation officer will participate in a fireside chat at CL King’s virtual 21st Annual Best Ideas Conference 2023 on Mon., Sept. 18 at approximately 8:45 a.m. Eastern Time.
September 12, 2023
·
1 min read
Press Releases
Universe Pharmaceuticals INC Announces Share Consolidation
March 20, 2025
·
3 min read
BioMidwest
Meitheal Pharmaceuticals Strengthens Biologics Portfolio with an Exclusive Commercial Licensing Agreement for YUSIMRY®, a Biosimilar of Humira®
Meitheal Pharmaceuticals, Inc. (“Meitheal”) today announced it has gained exclusive commercial rights in the U.S. to YUSIMRY® (adalimumab-aqvh), a biosimilar of Humira® (adalimumab), through an exclusive license and supply agreement with its parent company, Hong Kong King-Friend Industry Co., Ltd. (“HKF”).
June 27, 2024
·
16 min read
1 of 71,920
Next
